Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries

American Heart Journal

Volumn 168, Issue 2, 2014, Pages 142-149

  Greene, Stephen J ^a   Shah, Ami N ^a   Butler, Javed ^b   Ambrosy, Andrew P ^c   Anker, Stefan D ^d   Chioncel, Ovidiu ^e   Collins, Sean P ^f   Dinh, Wilfried ^g,h   Dunnmon, Preston M ⁱ   Fonarow, Gregg C ^j   Lam, Carolyn S P ^k   Mentz, Robert J ^l   Pieske, Burkert ^m   Roessig, Lothar ^h   Rosano, Giuseppe M C ⁿ   Sato, Naoki ^o   Vaduganathan, Muthiah ^p   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f VANDERBILT UNIVERSITY   (United States)

^g Witten University   (Germany)

^h BAYER PHARMA AG   (Germany)

ⁱ CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

^m Department of Cardiology ^*  (Austria)

ⁿ IRCC San Raffaele   (Italy)

^o NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DRUG DEVELOPMENT; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ACCESS; HEART FAILURE; HOSPITALIZATION; HUMAN; PATIENT SAFETY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; STUDY DESIGN; UNITED STATES; FOLLOW UP; HOSPITAL PATIENT; INVESTMENT; MEDICAL DEVICE; QUALITY CONTROL; REGISTER; WORKFLOW;

CLINICAL PROTOCOLS; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; GUIDELINE ADHERENCE; HEART FAILURE; HOSPITALIZATION; HUMANS; MULTICENTER STUDIES AS TOPIC; REGISTRIES; THERAPIES, INVESTIGATIONAL; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84905560606     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.05.009     Document Type: Article

References (55)

1. R.S. Velagaleti, M.J. Pencina, and J.M. Murabito et al. Long-term trends in the incidence of heart failure after myocardial infarction Circulation 118 2008 2057 2062
2. J.A. Ezekowitz, P. Kaul, and J.A. Bakal et al. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction J Am Coll Cardiol 53 2009 13 20
3. A.S. Adabag, R.V. Luepker, and V.L. Roger et al. Sudden cardiac death: epidemiology and risk factors. Nature reviews Cardiology 7 2010 216 225
4. P.A. Heidenreich, J.G. Trogdon, and O.A. Khavjou et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 2011 933 944
5. P.A. Heidenreich, N.M. Albert, and L.A. Allen et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association Circ Heart Fail 6 2013 606 619
6. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
7. K. Guha, and T. McDonagh Heart failure epidemiology: European perspective Curr Cardiol Rev 9 2013 123 127
8. A.P. Ambrosy, G.C. Fonarow, and J. Butler et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries J Am Coll Cardiol 63 2014 1123 1133
9. C. Mathers, D.M. Fat, and J. Boerma The global burden of disease: 2004 update 2008 World Health Organization
10. S. Yusuf, S. Reddy, and S. Ounpuu et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation 104 2001 2746 2753
11. G.F. Mendez, and M.R. Cowie The epidemiological features of heart failure in developing countries: a review of the literature Int J Cardiol 80 2001 213 219
12. S.W. Glickman, J.G. McHutchison, and E.D. Peterson et al. Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
13. Z.J. Eapen, J.P. Vavalle, and C.B. Granger et al. Rescuing clinical trials in the United States and beyond: a call for action Am Heart J 165 2013 837 847
14. A.P. Maggioni, U. Dahlstrom, and G. Filippatos et al. Eurobservational research programme: regional differences and 1-year follow-up results of the heart failure pilot survey (ESC-HF pilot) Eur J Heart Fail 15 2013 808 817
15. M. Gheorghiade, and A. Ambrosy Heart failure in 2010: one step forward, two steps back Nat Rev Cardiol 8 2011 72 73
16. M. Gheorghiade, F. Zannad, and G. Sopko et al. Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968
17. M. Gheorghiade, W.T. Abraham, and N.M. Albert et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
18. D.S. Lee, M.M. Mamdani, and P.C. Austin et al. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000 Am J Med 116 2004 581 589
19. A.P. Maggioni, S.D. Anker, and U. Dahlstrom et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC heart failure long-term registry Eur J Heart Fail 15 2013 1173 1184
20. M. Vaduganathan, S.J. Greene, and A.P. Ambrosy et al. The disconnect between phase II and phase III trials of drugs for heart failure Nat Rev Cardiol 10 2013 85 97
21. A. Ramírez, and W.H. Abelmann Cardiac decompensation N Engl J Med 290 1974 499 501
22. J. Butler, H. Subacius, and M. Vaduganathan et al. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial J Am Coll Cardiol 61 2013 571 579
23. M. Gheorghiade, M. Vaduganathan, and S.J. Greene et al. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions Heart Fail Rev 19 2014 135 152
24. M. Gheorghiade, P.S. Pang, and C.M. O'Connor et al. Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase Am Heart J 161 2011 224 232
25. J. Chen, S.L. Normand, and Y. Wang et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 2011 1669 1678
26. O. Chioncel, D. Vinereanu, and M. Datcu et al. The Romanian acute heart failure syndromes (RO-AHFS) registry Am Heart J 162 2011 142 e141 153 e141
27. K.F. Adams Jr., G.C. Fonarow, and C.L. Emerman et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE) Am Heart J 149 2005 209 216
28. B.A. Steinberg, X. Zhao, and P.A. Heidenreich et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes Circulation 126 2012 65 75
29. J.G. Cleland, K. Swedberg, and F. Follath et al. The euroheart failure survey programme - a survey on the quality of care among patients with heart failure in europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 2003 442 463
30. M.S. Nieminen, D. Brutsaert, and K. Dickstein et al. Euroheart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736
31. A.P. Maggioni, U. Dahlstrom, and G. Filippatos et al. Eurobservational research programme: the heart failure pilot survey (ESC-HF pilot) Eur J Heart Fail 12 2010 1076 1084
32. F. Oliva, A. Mortara, and G. Cacciatore et al. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian registry on heart failure outcome Eur J Heart Fail 14 2012 1208 1217
33. F. Zannad, A. Mebazaa, and Y. Juilliere et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study Eur J Heart Fail 8 2006 697 705
34. J. Spinar, J. Parenica, and J. Vitovec et al. Baseline characteristics and hospital mortality in the acute heart failure database (AHEAD) main registry Crit Care 15 2011 R291
35. N. Sato, K. Kajimoto, and T. Keida et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND registry) Circ J 77 2013 944 951
36. J.G. Cleland, T. McDonagh, and A.S. Rigby et al. The national heart failure audit for England and Wales 2008-2009 Heart 97 2011 876 886
37. J.J. Atherton, C.S. Hayward, and W.A. Wan Ahmad et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE international-Asia Pacific) J Card Fail 18 2012 82 88
38. F. Follath, M.B. Yilmaz, and J.F. Delgado et al. Clinical presentation, management and outcomes in the acute heart failure global survey of standard treatment (ALARM-HF) Intensive Care Med 37 2011 619 626
39. A. Damasceno, B.M. Mayosi, and M. Sani et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries Arch Intern Med 172 2012 1386 1394
40. E.R. Perna, A. Barbagelata, and L. Grinfeld et al. Overview of acute decompensated heart failure in Argentina: lessons learned from 5 registries during the last decade Am Heart J 151 2006 84 91
41. R. West, L. Liang, and G.C. Fonarow et al. Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-international registry Eur J Heart Fail 13 2011 945 952
42. M.A. Konstam, M. Gheorghiade, and J.C. Burnett et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 2007 1319 1331
43. C.M. O'Connor, R.C. Starling, and A.F. Hernandez et al. Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
44. J.R. Teerlink Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure Am Heart J 145 2003 S26 S33
45. M. Gheorghiade, M. Bohm, and S.J. Greene et al. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial JAMA 309 2013 1125 1135
46. A. Mebazaa, P.S. Pang, and M. Tavares et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study Eur Heart J 31 2010 832 841
47. R.L. West, A.F. Hernandez, and C.M. O'Connor et al. A review of dyspnea in acute heart failure syndromes Am Heart J 160 2010 209 214
48. J.R. Teerlink, G. Cotter, and B.A. Davison et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 381 2013 29 39
49. B.M. Massie Globalization of clinical trials how should we interpret differences in outcomes? J Am Coll Cardiol 58 2011 923 924
50. B. Pitt, M.A. Pfeffer, and S.F. Assmann et al. Spironolactone for heart failure with preserved ejection fraction N Engl J Med 370 2014 1383 1392
51. Meta-analysis Global Group in Chronic Heart F The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Eur Heart J 33 2012 1750 1757
52. C.N. Hess, S.V. Rao, and D.F. Kong et al. Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the study of access site for enhancement of percutaneous coronary intervention for women (SAFE PCI for women) Am Heart J 166 2013 421 428
53. O. Frobert, B. Lagerqvist, and G.K. Olivecrona et al. Thrombus aspiration during ST-segment elevation myocardial infarction N Engl J Med 369 2013 1587 1597
54. M.S. Lauer, and R.B. D'Agostino Sr. The randomized registry trial - the next disruptive technology in clinical research? N Engl J Med 369 2013 1579 1581
55. T. Svilaas, P.J. Vlaar, and I.C. van der Horst et al. Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567